非甾体抗炎药物的药理及临床应用进展

[1] Exacerbation of inflammationassociated colonic injury in rat through inhibition of cyclo-oxygenase-2. Reuter BK,Asfaha S,Buret A,et al. The Journal of Clinical Investigation . 1996

[2] Clinicalefficacyandtoler anceofnabumetoneinarticularandnonarticularrheumaticdisor ders:personalexperienceduring 12weeksoftreatment. CoaccioliS,AllegraA,DiCatoL,etal. Pan minervaMed . 1998

[3] Involvement of nuclear factor kappa b in the regulation of cyclo-oxygenase-2-expression by interleukin-1 in rheumatoid synoviocytes. Crofford LJ,Tan B,Mccarthy CJ,et al. Arthritis and Rheumatism . 1997

[4] Cyclooxygenase 1andcyclooxygenase 2se lectivityofwidelyusednonsteroidalantiinflammatorydrugs. CryerB,FeldmanM. The American Journal of The Medical Sciences . 1998

[5] Gastrointestinal tolerability ofmeloxicam compared to diclofenac in osteoarthritis patients. Hawkey C,Kaham A,Steinbruck,et al. British Journal of Rheumatology . 1998

[6] Regulationofprostaglandinproductionbynitricoxide :aninvivoanalysis. SalveminiD,SettleSL,MasferrerJL,etal. British Journal of Pharmacology . 1995

[7] Cyclo-oxygenase isoenzymes.How recent findings affect thinking about nonsteroidal anti-inflammatory drugs. Jouzeau JY,Terlain B,Abid A,et al. Drugs . 1997

[8] Anti inflammatorypotencyandgastrointestinaltoxicityofanewcompound ,no naproxen. CuzzolinL,ConforiA,AdmiA,etal. Pharmacological Research . 1995

[9] Targets for anti-inflammatory drugs. Cronstein BN,Weissmann C. Annual Review of Pharmacology . 1995

[10] Inhibition of human coloncancer cell growth by selective inhibition of cy-clooxygenase-2. Sheng H,Shao J,Kirkland SC,et al. The Journal of Clinical Investigation . 1997

[1] Exacerbation of inflammationassociated colonic injury in rat through inhibition of cyclo-oxygenase-2. Reuter BK,Asfaha S,Buret A,et al. The Journal of Clinical Investigation . 1996

[2] Clinicalefficacyandtoler anceofnabumetoneinarticularandnonarticularrheumaticdisor ders:personalexperienceduring 12weeksoftreatment. CoaccioliS,AllegraA,DiCatoL,etal. Pan minervaMed . 1998

[3] Involvement of nuclear factor kappa b in the regulation of cyclo-oxygenase-2-expression by interleukin-1 in rheumatoid synoviocytes. Crofford LJ,Tan B,Mccarthy CJ,et al. Arthritis and Rheumatism . 1997

[4] Cyclooxygenase 1andcyclooxygenase 2se lectivityofwidelyusednonsteroidalantiinflammatorydrugs. CryerB,FeldmanM. The American Journal of The Medical Sciences . 1998

[5] Gastrointestinal tolerability ofmeloxicam compared to diclofenac in osteoarthritis patients. Hawkey C,Kaham A,Steinbruck,et al. British Journal of Rheumatology . 1998

[6] Regulationofprostaglandinproductionbynitricoxide :aninvivoanalysis. SalveminiD,SettleSL,MasferrerJL,etal. British Journal of Pharmacology . 1995

[7] Cyclo-oxygenase isoenzymes.How recent findings affect thinking about nonsteroidal anti-inflammatory drugs. Jouzeau JY,Terlain B,Abid A,et al. Drugs . 1997

[8] Anti inflammatorypotencyandgastrointestinaltoxicityofanewcompound ,no naproxen. CuzzolinL,ConforiA,AdmiA,etal. Pharmacological Research . 1995

[9] Targets for anti-inflammatory drugs. Cronstein BN,Weissmann C. Annual Review of Pharmacology . 1995

[10] Inhibition of human coloncancer cell growth by selective inhibition of cy-clooxygenase-2. Sheng H,Shao J,Kirkland SC,et al. The Journal of Clinical Investigation . 1997